IRIS
IANNONE, Florenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.629
AS - Asia 8.906
EU - Europa 8.364
SA - Sud America 2.374
AF - Africa 373
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 16
Totale 42.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.226
SG - Singapore 3.822
IT - Italia 2.849
CN - Cina 1.878
BR - Brasile 1.856
FR - Francia 1.143
HK - Hong Kong 1.094
SE - Svezia 1.009
RU - Federazione Russa 886
DE - Germania 758
VN - Vietnam 581
FI - Finlandia 575
GB - Regno Unito 437
IN - India 287
BD - Bangladesh 273
AR - Argentina 185
CA - Canada 182
UA - Ucraina 167
IQ - Iraq 135
ID - Indonesia 134
TR - Turchia 117
MX - Messico 116
ZA - Sudafrica 100
JP - Giappone 87
PK - Pakistan 87
CI - Costa d'Avorio 82
EC - Ecuador 77
BE - Belgio 72
ES - Italia 68
SA - Arabia Saudita 68
CO - Colombia 67
VE - Venezuela 62
PL - Polonia 57
IE - Irlanda 55
NL - Olanda 53
AT - Austria 52
PH - Filippine 45
UZ - Uzbekistan 45
MA - Marocco 42
CL - Cile 35
PY - Paraguay 35
CZ - Repubblica Ceca 28
JM - Giamaica 28
LT - Lituania 28
TN - Tunisia 27
IR - Iran 24
KE - Kenya 24
MY - Malesia 23
JO - Giordania 21
PE - Perù 21
EG - Egitto 20
ET - Etiopia 20
CH - Svizzera 19
BO - Bolivia 17
NP - Nepal 16
EU - Europa 15
OM - Oman 15
AZ - Azerbaigian 14
KZ - Kazakistan 14
DZ - Algeria 13
TH - Thailandia 13
AU - Australia 12
PA - Panama 12
UY - Uruguay 12
AM - Armenia 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
LB - Libano 10
NI - Nicaragua 10
PS - Palestinian Territory 10
RS - Serbia 10
DK - Danimarca 9
DO - Repubblica Dominicana 9
HN - Honduras 9
IL - Israele 9
PT - Portogallo 9
AL - Albania 8
BG - Bulgaria 8
BH - Bahrain 8
KG - Kirghizistan 8
SN - Senegal 8
HR - Croazia 7
MD - Moldavia 7
QA - Qatar 7
AO - Angola 6
BB - Barbados 6
KR - Corea 6
RO - Romania 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
GF - Guiana Francese 5
GR - Grecia 5
HU - Ungheria 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
EE - Estonia 4
MM - Myanmar 4
MU - Mauritius 4
NO - Norvegia 4
Totale 42.594
Salva come PNG Salva come JPEG
Città #
Fairfield 2.591
Ashburn 2.310
Singapore 2.067
Woodbridge 1.845
Houston 1.417
Chandler 1.364
San Jose 1.211
Milan 1.092
Hong Kong 1.083
Seattle 1.080
Cambridge 936
Ann Arbor 922
Wilmington 816
Nyköping 800
Beijing 598
Jacksonville 431
Dallas 406
Lauterbourg 384
Rome 362
Lawrence 323
New York 315
Roxbury 311
Helsinki 301
Los Angeles 284
Munich 282
Nanjing 256
Bari 240
Des Moines 203
São Paulo 180
Princeton 176
Columbus 175
Ho Chi Minh City 174
Inglewood 172
Santa Clara 172
Boardman 168
Council Bluffs 156
Hanoi 122
Falkenstein 120
Buffalo 118
San Diego 118
Moscow 114
London 112
Brooklyn 110
Figino 104
Chicago 90
Abidjan 81
Dearborn 80
Turku 79
Paris 75
Shenyang 75
Jakarta 74
Brussels 71
Tokyo 68
The Dalles 62
Frankfurt am Main 60
Rio de Janeiro 60
Hebei 59
Montreal 57
Turin 56
Baghdad 54
Dublin 54
Dong Ket 52
Jiaxing 52
Nanchang 51
Atlanta 50
Johannesburg 50
Warsaw 49
Denver 47
San Francisco 47
Toronto 47
Belo Horizonte 44
Boston 44
Orem 42
Dhaka 41
Poplar 40
Mexico City 39
Tianjin 39
Nuremberg 38
Tashkent 38
Changsha 36
Chennai 36
Phoenix 36
Brasília 35
Stockholm 35
Lahore 34
Manchester 33
Redwood City 31
Bar Harbor 29
Guangzhou 29
Pune 29
Shanghai 28
Naples 27
Bologna 26
Curitiba 26
Vienna 26
Campinas 25
Ankara 24
Mumbai 24
Quito 24
Riyadh 24
Totale 29.103
Salva come PNG Salva come JPEG
Nome #
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 232
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis 231
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 228
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 225
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 208
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 207
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 198
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 194
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 193
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 192
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 187
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 186
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 186
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 185
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 185
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 183
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 179
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 178
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 177
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 177
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 176
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 174
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 172
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 172
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 171
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 170
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 169
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 169
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 168
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 168
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 167
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 166
Digital ulcers predict a worse disease course in patients with systemic sclerosis 166
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 165
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 165
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 164
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 163
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 163
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 162
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 161
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 161
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 160
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 160
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 158
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 155
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 155
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 154
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers 154
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 154
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 152
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 152
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 151
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 151
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 150
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 149
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 149
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 147
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 147
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 146
Chondrocytes treated with different shock wave devices 146
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 146
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 144
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 143
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 143
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 142
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 141
Serum amyloid-A in Behçet's disease 141
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 141
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 140
Peripheral and central nervous system correlates in fibromyalgia 140
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 140
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 139
Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results 138
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 138
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 137
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 137
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 136
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 135
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 135
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 134
Management of Small Vessel Vasculitides 134
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 133
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 132
Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology 132
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 132
Untangling the web of systemic autoinflammatory diseases 132
Obesity and Inflammation – Targets for OA Therapy 131
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 131
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 131
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 131
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 130
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 129
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 129
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 129
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 129
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 129
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database 128
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 127
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration 127
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA 126
Totale 15.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.494 191 220 41 125 109 185 163 146 153 171 344 646
2022/20233.717 575 439 289 301 364 495 78 433 545 28 108 62
2023/20241.250 105 260 58 98 105 267 38 60 15 47 32 165
2024/20256.640 145 91 482 157 139 616 635 774 335 405 1.000 1.861
2025/202615.643 1.967 622 910 1.691 1.861 931 1.697 529 1.463 1.508 458 2.006
2026/2027577 577 0 0 0 0 0 0 0 0 0 0 0
Totale 44.348